| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2caaba601fd6460c7b37706d920d42e2 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2027
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2059 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2018
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-095
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-095 |
| filingDate |
2004-07-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2007-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_44f69d482863a22967fc9ce2c1e2aa65
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7e0b76426323accd3207e623bc276fc7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aa9d09c31f0d04df61c132419886c43e |
| publicationDate |
2007-07-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
RU-2303439-C2 |
| titleOfInvention |
Desmopressin pharmaceutical composition as solid dosed medicinal formulation and method for its preparing |
| abstract |
FIELD: medicine, pharmacy. n SUBSTANCE: invention describes a pharmaceutical composition as a solid dosed medicinal formulation comprising desmopressin acetate as a therapeutic component in combination with a pharmaceutically acceptable excipient, diluting agent or carrier or their mixture. This pharmaceutical composition consists of pressed granulate and comprises a lubricating substance in the amount from 0.05 to less 0.40 wt.-% of indicated pharmaceutical composition mass. Indicated amount of lubricant provides increasing both pressing rate and strength of prepared tablets simultaneously. n EFFECT: improved and valuable pharmaceutical properties of composition. n 35 cl, 2 dwg, 1 ex |
| priorityDate |
2003-07-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |